Determinants of Medication Adherence Among Iranian Elderly Patients with Chronic Diseases

AUTHORS

Zahra Taheri Kharameh 1 , 2 , Sahar Khoshravesh 2 , 3 , * , Roghayeh Noori 4 , Mahsa Abdolmalaki 5 , Mohammad Bakhshi 1

1 School of Paramedical Sciences, Qom University of Medical Sciences, Qom, IR Iran

2 Students Research Committee, Hamadan University of Medical Sciences, Hamadan, IR Iran

3 Department of Public Health, School of Public Health, Hamadan University of Medical Sciences, Hamadan, IR Iran

4 Health Education and Health Promotion, Kurdistan University of Medical Sciences, Sanandaj, IR Iran

5 Kurdistan University of Medical Sciences, Kurdistan, IR Iran

How to Cite: Taheri Kharameh Z, Khoshravesh S, Noori R, Abdolmalaki M, Bakhshi M. Determinants of Medication Adherence Among Iranian Elderly Patients with Chronic Diseases, Jundishapur J Chronic Dis Care. 2018 ; 7(3):e68310. doi: 10.5812/jjcdc.68310.

ARTICLE INFORMATION

Jundishapur Journal of Chronic Disease Care: 7 (3); e68310
Published Online: July 21, 2018
Article Type: Research Article
Received: March 5, 2018
Revised: June 20, 2018
Accepted: July 8, 2018
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: One of the most important problems of the elderly with chronic diseases is lack of medication adherence that imposes huge costs on every country health care system.

Objectives: The aim of present study was to examine effective determinants on medication adherence in elderly patients with chronic diseases.

Methods: A cross-sectional survey was conducted at two teaching hospitals in Qom, Iran, in 2016. A total of 100 patients aged 60 and older were selected by convenience sampling. Data collection tools were three questionnaires such as Morisky medication adherence scale (MMAS-8), brief illness perception questionnaire (B-IPQ), hospital anxiety, and depression scale (HADS). Multiple logistic regression analysis was performed for statistical assessment.

Results: The mean and standard deviation age of the patients was 65.4 ± 5.2. More than two-thirds of the patients (71.4%) had poor medication adherence. In addition, among the variables entered into the multiple logistic regression model with P < 0.15 only Identify had a positive significant relationship with medication adherence (OR = 1.52, P = 0.010).

Conclusions: Medication adherence in elderly patients with chronic diseases was poor and illness perceptions were effective in medication adherence in elderly with chronic diseases.

Keywords

Medication Adherence Elders Chronic Disease Iran

Copyright © 2018, Jundishapur Journal of Chronic Disease Care. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited

1. Background

Aging is a global phenomenon that in the near future will be proposed as one of the public health challenges in the world, especially in developing countries (1). Ageing is an inevitable truth and critical period of human life. It is a natural and physiological process, which is time dependent and stared from birth and continued until death (2, 3). The age of ageing is considered 65 years in developed countries and 60 years for developing countries (4). The number of elderly people is quickly growing in the world, Therefore, today there are more than 600 million elder people all around the world, which is predicted to double until 2025, and in 2050 there will be two billion people, with the majority of them living in developing countries (5). The aging phenomenon in Asians occurs faster than western countries (6). In addition, Iran is no exception as one of the Asian countries. Iran is at the of demographics transition from youth to old age. A total of 6.8% of the Iran’s population is elderly people, which by 2030 it will become 10 million of the total population (7). By changing the demography and increasing the aging population around the world, the burden of chronic diseases is rapidly increasing (8). A study shows that at least 80% of elder individuals have chronic diseases (9).

One of the most important problems of elderly with chronic diseases is lack of medication adherence, which estimates a total of 28% of annual elderly hospitalization due to the lack of medication adherence problems (10). According to WHO definition, medication adherence defined as a rate of behavior consistent with recommendations made by health care personnel such as taking medication, diet, and changes in lifestyle (11). One important challenge in order to achieve therapeutic goals is lack of medication adherence (12). Results of the study in America showed that 50% of patients with chronic diseases have no treatment adherence (13). The results of a review study showed that medication adherence in anti-diabetic treatment, blood pressure, and blood fat in patients are low (14). Causes of medication non-adherence is often multifactorial, however, among the causes of low medication adherence can be cited to cases such as, patients giving importance to their medication, medication side effect, time-consuming and costly treatments (15, 16), personal characteristics, and doctor-patient relationship (17).

Little has been documented on the cause of poor compliance; therefore, this study was conducted to investigate influencing factors on medication adherence with using illness perception. It may be beneficial for health care providers to pay attention to patients’ illness perceptions, including their negative emotional symptoms, in order to improve their drug adherence.

In addition, due to the complex nature of lack of medication adherence and the importance of tenaciously care in elderly patients with chronic diseases, this issue needs to be investigated. For elderly people with chronic diseases, non-adherence to medication regimens can result in the increased use of medical resources, such as hospitals, physician visits, and unnecessary treatment. Furthermore, non-adherence to medication regimens may also result in therapeutic failure. Consequently, in elderly individuals suffering from chronic diseases, medication nonadherence is a growing concern to health care providers as well as health care systems, due to the mounting evidence that it is prevalent and associated with adverse outcomes and higher costs of care (18).

2. Objectives

The aim of present study was to examine the effective determinants on medication adherence in elderly patients with chronic diseases.

3. Methods

This cross-sectional study was conducted in Qom, a city in the center of Iran, in 2016. The study population included all hospitalized elderly patients with chronic diseases (cardiovascular disease, diabetes, asthma, and kidney failure) in Shahid Beheshti and Kamkar hospital in Qom city. A total of 100 patients aged 60 and older in the mentioned hospitals were selected by using simple sampling. The inclusion criteria to the study were: lack of cognitive problems, had detected chronic diseases with history of more than 6 moths, the ability to communicate in Farsi, and consent to participate in the study. Verbal informed consent for the study was obtained from all the selected patients. The ethics committee of the Qom University of Medical Sciences to No. IR.MUQ.REC.1395.86 approved this study. After receiving permission from Qom University of Medical Sciences and to the officials of health and education centers, permission required for the study was received. Every day one of the researchers refer to the sections and aforementioned clinic for collecting data, and after expressing the aim of study to the patient and getting their consent, the patient was given a questionnaire. If the patient, due to illiteracy was not able to complete the questionnaire, the questions were read by the researcher for the patient to answer; medical information was extracted from patients records. Data collection tools in this study included a questionnaire that consisted of four parts, which was completed by interviews.

The first part was related to demographic characteristics such as age, sex, education level, marital status, housing, occupational status, smoking, and time of diagnosis.

The second part of the questionnaire was assessing the perception of the disease in order to measure it used from the brief from of the brief illness perception questionnaire. This questionnaire has 9 items and was designed based on the revised form of the same questionnaire by Broadbent et al. (19). Each item measured a component of the patient’s perception. Five items measures cognitive reactions to disease that includes perception of consequences, duration of illness, personal control, treatment control, and recognizing the signs. Two items measures concerns about disease, emotional reactions to disease, and on item the ability to understand disease. Items five have been open responses and questioned three causes of diseases. The range of scores in the first eight items is 1 to 10. Cronbach’s alpha for this questionnaire reported 0.8 and test- retest reliability coefficient within 6 weeks for different questions reported from 0.42 to 0.75.

The third part was about medication adherence that was examined by using Morisky medication adherence scale (MMAS- 8). It has seven items with two scores (yes 0, and No 1 score) and one items with five scores (Never = 0, rarely = 1, sometimes = 3, often = 3 and always = 4 scores). Scoring up to six is considered as a desirable medication adherence (20). Moharamzad et al. (21), approved the validity and reliability of the Iranian version. Internal consistency was acceptable with an overall Cronbach’s coefficient of 0.697 and test-retest reliability showed good reproducibility.

In addition, in the forth section of depression and anxiety of patients were assessed by hospital anxiety and depression scale (HADS). This scale has 14 items; seven items reviews anxiety and seven items review depression. Each item is scored in multiple choice (almost never = 1, most of the time = 2, almost always = 3). Finally, according to the total 21 points in each section, a score higher than eight in each section are considered as anxiety and depression. Psychometric properties of the HADS were satisfactory. Cronbach’s alpha coefficient (to test reliability) has been found to be 0.78 for the HADS anxiety sub-scale and 0.86 for the HADS depression sub-scale. Validity performed using known groups comparison analysis showed satisfactory results (22).

Data were analyzed using SPSS software version 16 by Kolmogorov-Smirnov test, independent t-test, chi-square, and univariate and multiple logistic regression in order to controlling demographic, clinical, and mental variables. Significant level in all of statistical tests was considered less than 0.05.

4. Results

The results of the present study showed that the average age of the participants was 65.4 ± 5.2 and 51 were female. More than half of the elderly (n = 72) were illiterate or had an elementary education; most of them were married (n = 72). A total of 83% of individuals were living their home. Only 29 people were employed. The mean and standard deviation (SD) duration of disease was reported 8.58 ± 8.02 in a year. In Table 1, the demographic characteristics of people in the study have been described.

Table 1. Patients’ Demographic Characteristics and Medical History (n = 100)a
VariablesValues
Age (y)65.4 ± 5.2
Gender
Male49
Female51
Educational status
Illiterate44
Primary school28
High school19
Secondary school9
Marital status
Single2
Married71
Divorced/ widowed27
Employment status
Employed29
Unemployed30
housewife41
Economic status
Poor64
Good36
Smoking status
Smoker34
Non-smoker66
Duration of disease, y8.58 ± 8.02
Medical history
Heart disease55
Hypertension48
Diabetes mellitus23
Asthma5
Kidney failure20

a Values are presented as No. or Mean ± SD.

Medication adherence mean and SD score in elderly was 5.06 ± 2.52. The highest score related to mean and SD of perception of disease score was 7.76 ± 2.85, while the lowest score related to personal control item with 4.27 ± 3.50 mean and SD. The mean and SD score of anxiety in patients was 11.67 ± 3.33, while depression had a mean and SD score of 10.47 ± 3.76 (Table 2).

Table 2. Descriptive Statistics of Medication Adherence, Illness Perception and HADS
VariablesMean ± SD
Medication adherence5.06 ± 2.52
Illness perception
Consequences7.76 ± 2.85
Timeline7.66 ± 2.99
Personal control4.27 ± 3.50
Treatment control7.40 ± 2.93
Identity6.51 ± 2.72
Illness concern7.25 ± 3.37
Emotional representation6.83 ± 2.78
HADS
Anxiety11.67 ± 3.33
Depression10.47 ± 3.76

Among demographic, clinical, and psychological variables, only depression had a significant inverse relationship with medication adherence (r = 0.22, P = 0.020). Among illness perception variables, Identify (r = 0.23, P = 0.021) and personal control (r = 0.19, P = 0.043) had positive and significant relationship with medication adherence, which means that people who had more recognition of symptoms also had better medication adherence.

The results of univariate logistic regression model showed that two variables of personal control and identifying symptoms have significant and positive relationship with medication adherence. Therefore, by increasing one unit in personal control, the variable chance of medication adherence was almost 1.1 (OR = 1.12, CI = 1.08 - 1.83). In personal control variable the chance of medication adherence was nearly 1.1 times (OR = 1012, CI = 1.08 - 1.83). In addition, by increasing one unit in Identify, 1.5 times (OR = 1.46, CI = 1.14 - 1.87). The results of multiple logistic regression showed that among entered variable into the multiple logistic regression model P < 0.15 only Identify had significant positive relationship with medication adherence. In other words, for one unit increase in the Identify variable the chance of medication adherence increased 1.5 times (OR = 1.52, CI = 1.08 - 2.13) (Table 3).

Table 3. Multiple Logistic Regression Model to Assess Factors Influencing Medication Adherence
VariablesBSEOR95% CIP
BMI0.070.051.070.96 - 1.190.182
Gender0.820.660.430.12 - 1.600.210
Disease duration0.050.051.050.94 - 1.170.341
Timeline0.020.131.020.79 - 1.320.865
Personal control0.060.091.020.77 - 1.130.501
Identity0.420.171.521.08 - 2.130.010
Illness concern0.050.111.050.83 - 1.330.638
Emotional representation0.090.111.100.88 - 1.370.393
Depression0.140.100.990.80 - 1.220.951
Anxiety-0.010.121.150.90 - 1.470.244

5. Discussion

The aim of the present study is to review effective determinants in medication adherence in elderly patients with chronic diseases. Medication adherence in under study elderly was not desirable, and more than two-thirds (71.4%) of patients took a score less than six and had undesirable medication adherence.

Based on our study findings the only main significant medication adherence determinative after controlling demographic, clinical, and psychological variable was Identify. This means that elderly who had more recognition of symptoms and had experienced symptoms and had more desirable medication adherence. This finding was consistent with the results of a university in America, therefore, those who had little recognition of bronchial asthma symptoms had less medication adherence (13), however, this finding had an inconsistency with another study in Libya. In that study, people who had experienced diabetes symptoms had lower medication adherence (23). This contradiction can be justified by the reasons that in the Iranian culture patients go to the doctor if they experience symptoms and they try to control their symptoms by compelling prescribed treatment. It seems that in Iran, as long as people do not experience symptoms of a disease, they are not doing the necessary treatments. In fact, based on the perception of people regarding the symptoms, severity of them, and beliefs about the possible symptoms consequences, reactions of people about treatment will be change (24). Therefore, it seems that in order to implement effective interventions for increasing medication adherence in recognition the diseases, special attention to culture should be given. The results of this study showed that another effective illness perception variable on medication adherence was personal control, in another words, the elderly who believes they can manage and control their disease had more medication adherence. According to the results of studies, high personal control over the diseases will lead to greater medication adherence (19, 25). Like to our study, Mosleh’s study (26) results in Jordan showed that patients with coronary artery disease, which is believed to have a greater ability to control their disease have a greater motivation to comply with the desirable treatment the results of this study with other results of the study about asthma, diabetes, and cardiovascular were consistent (27, 28). In people with asthma (13) and high blood pressure those who had more control over their diseases could improved their lifestyle and avoided from diseases that exacerbated them. This result showed that effective interventions in order to strengthen personal control items can facilitate the lifestyle modification and will upgrade the ability of people in self-management skills (29).

This study also had limitations including being cross-sectional, which does not provide a cause and effect relationship between variables. The data was collected by self-reporting, which may not reflect the actual performance of subjects. In addition, non-random sampling and limited sample size in this study reduce the generalizability of findings; performing this study with a larger sample size can be effective in promoting these limits. There are many variables that may have an effect on medication adherence, which has not been studied in our study, therefore, recommended future studies are done by more variables such as confronting strategies, self efficacy, fear, and etc.

5.1. Conclusions

The study showed that medication adherence rate in elderly with chronic diseases were undesirable, and Identify variable of the illness perception was an effective factor on medication adherence in elderly with chronic diseases. Thus, enhancing patient’s perception, especially this mentioned item in order to increase the patients’ medication adherence in educational and health interventions, is necessary.

Acknowledgements

References

  • 1.

    Darvishpoor Kakhki A, Abed Saeedi J, Delavar A, Saeed O Zakerin M. Instrument development to measure elderly health-related quality of life (EHRQoL). Hakim Res J. 2012;15(1):30-7.

  • 2.

    Memarian R. [Application of nursing concepts and theories]. Tehran: Asare Elmi Publication; 1999. Persian.

  • 3.

    Timby BK, Smith NE. Introductory Medical-Surgical Nursing. Lippincott Williams and Wilkins; 2013.

  • 4.

    Bloom DE, Boersch-Supan A, McGee P, Seike A. Program on the Global Demography of Aging. PGDA Working Paper. 2011.

  • 5.

    World Health Organization. World Report on Ageing and Health. Geneva: World Health Organization; 2015.

  • 6.

    Noroozian M. The elderly population in iran: an ever growing concern in the health system. Iran J Psychiatry Behav Sci. 2012;6(2):1-6. [PubMed: 24644476]. [PubMed Central: PMC3940007].

  • 7.

    Ahmadi F, Salar A, Faghihzadeh S. [Quality of Life in Zahedan Elderly Population]. J Hayat. 2004;10(3):61-7. Persian.

  • 8.

    Pishkar Mofrad Z, Jahantigh M, Arbabisarjou A. Health Promotion Behaviors and Chronic Diseases of Aging in the Elderly People of Iranshahr, IR Iran. Glob J Health Sci. 2015;8(3):139-45. doi: 10.5539/gjhs.v8n3p139. [PubMed: 26493431]. [PubMed Central: PMC4803959].

  • 9.

    Barry PP. An overview of special considerations in the evaluation and management of the geriatric patient. Am J Gastroenterol. 2000;95(1):8-10. doi: 10.1111/j.1572-0241.2000.01697.x. [PubMed: 10638552].

  • 10.

    Administration on Aging. Medication Management, 2015. Administration for Community Living; 2015. Available from: www.aoa.gov/AoA_Programs/HPW/Med_Manage/index.aspx.

  • 11.

    Sabate E, Sabaté E; Organisation mondiale de la santé; World Health Organization; UNAIDS. Adherence to Long-term Therapies: Evidence for Action. World Health Organization; 2003.

  • 12.

    Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB. Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study. Am J Kidney Dis. 2010;56(3):439-46. doi: 10.1053/j.ajkd.2010.04.021. [PubMed: 20674113]. [PubMed Central: PMC2935303].

  • 13.

    Unni E, Shiyanbola OO. Clustering medication adherence behavior based on beliefs in medicines and illness perceptions in patients taking asthma maintenance medications. Curr Med Res Opin. 2016;32(1):113-21. doi: 10.1185/03007995.2015.1105204. [PubMed: 26443294].

  • 14.

    Karamanidou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrology. 2008;9(1). doi: 10.1186/1471-2369-9-2.

  • 15.

    Cinar S, Barlas GU, Alpar SE. Stressors and Coping Strategies in Hemodialysis Patients. Pak J Med Sci. 2009;25(3):447-52.

  • 16.

    Sharp J, Wild MR, Gumley AI. A systematic review of psychological interventions for the treatment of nonadherence to fluid-intake restrictions in people receiving hemodialysis. Am J Kidney Dis. 2005;45(1):15-27. [PubMed: 15696440].

  • 17.

    Hadi N, Rostami-Gooran N. Determinant factors of medication compliance in hypertensive patients of Shiraz. Arch Iran Med. 2004;7(4):292-6.

  • 18.

    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97. doi: 10.1056/NEJMra050100. [PubMed: 16079372].

  • 19.

    Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631-7. doi: 10.1016/j.jpsychores.2005.10.020. [PubMed: 16731240].

  • 20.

    Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54. [PubMed: 18453793]. [PubMed Central: PMC2562622].

  • 21.

    Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients. Glob J Health Sci. 2015;7(4):173-83. doi: 10.5539/gjhs.v7n4p173. [PubMed: 25946926]. [PubMed Central: PMC4802120].

  • 22.

    Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Out. 2003;1(1):14.

  • 23.

    Ashur ST, Shah SA, Bosseri S, Morisky DE, Shamsuddin K. Illness perceptions of Libyans with T2DM and their influence on medication adherence: a study in a diabetes center in Tripoli. Libyan J Med. 2015;10:29797. doi: 10.3402/ljm.v10.29797. [PubMed: 26714569]. [PubMed Central: PMC4695620].

  • 24.

    Lau RR. Cognitive representations of health and illness. In: Gochman DS, editor. Handbook of Health Behavior Research I: Personal and Social Determinants. New York: Plenum: Springer; 1997. p. 51-69.

  • 25.

    Hagger MS, Orbell S. A Meta-Analytic Review of the Common-Sense Model of Illness Representations. Psychol Health. 2003;18(2):141-84. doi: 10.1080/088704403100081321.

  • 26.

    Mosleh SM, Almalik MM. Illness perception and adherence to healthy behaviour in Jordanian coronary heart disease patients. Eur J Cardiovasc Nurs. 2016;15(4):223-30. doi: 10.1177/1474515114563885. [PubMed: 25505161].

  • 27.

    MacInnes J. Relationships between illness representations, treatment beliefs and the performance of self-care in heart failure: a cross-sectional survey. Eur J Cardiovasc Nurs. 2013;12(6):536-43. doi: 10.1177/1474515112473872. [PubMed: 23315127].

  • 28.

    Mosleh SM, Bond CM, Lee AJ, Kiger A, Campbell NC. Effectiveness of theory-based invitations to improve attendance at cardiac rehabilitation: a randomized controlled trial. Eur J Cardiovasc Nurs. 2014;13(3):201-10. doi: 10.1177/1474515113491348. [PubMed: 23733348].

  • 29.

    Lo SH, Chau JP, Woo J, Thompson DR, Choi KC. Adherence to Antihypertensive Medication in Older Adults With Hypertension. J Cardiovasc Nurs. 2016;31(4):296-303. doi: 10.1097/JCN.0000000000000251. [PubMed: 25774846]. [PubMed Central: PMC4915757].

  • COMMENTS

    LEAVE A COMMENT HERE: